Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Bohnsack

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Infection and Immunity|April 1, 1993
Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal speciesJ F Bohnsack, J K Chang, H R Hill
The Journal of Clinical Investigation|February 1, 1988
Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigenE J Brown, J F Bohnsack, H D Gresham
Journal of Leukocyte Biology|April 1, 1995
Mechanisms of beta 1 integrin-dependent adherence of granulocytic HL60 to fibronectinJ F Bohnsack, J Chang, X Zhou, et al.
Journal of Cellular Physiology|April 3, 1998
Intracellular calcium requirements for beta1 integrin activationM E Rowin, R E Whatley, T Yednock, et al.
The Journal of Rheumatology|February 24, 2000
Childhood polyarteritis nodosa presenting as a relapsing movement disorderE E Adderson, J A Thompson, A Lowichik, et al.
American Journal of Medical Genetics|March 21, 1998
Clinical analysis of a variant of Freeman-Sheldon syndrome (DA2B)P A Krakowiak, J F Bohnsack, J C Carey, et al.
American Journal of Medical Genetics|November 11, 1996
Distal arthrogryposis type 1: clinical analysis of a large kindredM Bamshad, J F Bohnsack, L B Jorde, et al.
Molecular Immunology|March 1, 1987
Evidence for a conformational change in human fibronectin which occurs between 4 and 37 degrees CE J Brown, J F Bohnsack, J J O'Shea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1)J F Bohnsack, J J O'Shea, T Takahashi, et al.
Pediatrics|July 2, 1999
Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteriaM T Witt, L L Minich, J F Bohnsack, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Infection and Immunity|April 1, 1993
Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal speciesJ F Bohnsack, J K Chang, H R Hill
The Journal of Clinical Investigation|February 1, 1988
Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigenE J Brown, J F Bohnsack, H D Gresham
Journal of Leukocyte Biology|April 1, 1995
Mechanisms of beta 1 integrin-dependent adherence of granulocytic HL60 to fibronectinJ F Bohnsack, J Chang, X Zhou, et al.
Journal of Cellular Physiology|April 3, 1998
Intracellular calcium requirements for beta1 integrin activationM E Rowin, R E Whatley, T Yednock, et al.
The Journal of Rheumatology|February 24, 2000
Childhood polyarteritis nodosa presenting as a relapsing movement disorderE E Adderson, J A Thompson, A Lowichik, et al.
American Journal of Medical Genetics|March 21, 1998
Clinical analysis of a variant of Freeman-Sheldon syndrome (DA2B)P A Krakowiak, J F Bohnsack, J C Carey, et al.
American Journal of Medical Genetics|November 11, 1996
Distal arthrogryposis type 1: clinical analysis of a large kindredM Bamshad, J F Bohnsack, L B Jorde, et al.
Molecular Immunology|March 1, 1987
Evidence for a conformational change in human fibronectin which occurs between 4 and 37 degrees CE J Brown, J F Bohnsack, J J O'Shea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1)J F Bohnsack, J J O'Shea, T Takahashi, et al.
Pediatrics|July 2, 1999
Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteriaM T Witt, L L Minich, J F Bohnsack, et al.
Pageof 6